Since 1967, we have been innovating to support scientific and technological progress in the service of diagnosis, prevention and precision medicine for all.
Alongside associations and its public and institutional partners, the Cerba Institute is mobilizing to support patients, health professionals and research teams.
Working towards better tuberculosis screening in developing countries: EpiLAB joins the Cerba HealthCare Group's virtual incubator
Press release
28 October 2021
Cerba HealthCare completes acquisition of Lifebrain in Italy
News
22 October 2021
Cerba selected to participate in COVID 19 sequencing
News
21 October 2021
Cerba HealthCare receives the Happy Trainees label
News
13 September 2021
Cerba: a study published in JAMA
Press release
24 August 2021
Cerba Research and ACT Genomics announce strategic joint venture — CerbACT Asia
News
19 August 2021
A quarter of severe forms of Covid-19 can be explained by a genetic or immunological abnormality
Press release
22 July 2021
Cerba HealthCare pursues its growth strategy with the acquisition of Lifebrain in Italy
Press release
19 July 2021
METAFORA biosystems, l’AP-HP ET Cerba HealthCare ont présenté les résultats de l’étude de validation du test METAglut1 lors du 3ème congrès européen sur le syndrome de deficit en Glut1.
Press release
21 June 2021
Covid-19: Laboratoire Cerba ready to sequence on a larger scale